Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| FKA-H5122 | Human | Human FKBP12 / FKBP1A Protein, His Tag |  |
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Tacrolimus Hydrate | FR-900506; L-679934; FK-506MR; FK-506E; FK-506; MR-4; RTU-007; LCP-Tacro | Approved | Astellas Pharma Inc | Protopy, Graceptor (as hydrate), Protopic, Prograf (as hydrate), Hecoria (as hydrate), Hexal, Envarsus XR, Talymus, 普乐可复, Advagraf, Envarsus, Modigraf, Astagraf XL, TacroBell | United States | Rejection of lung transplantation | Astellas Pharma Us Inc | 1993-01-01 | Wounds and Injuries; Rejection of organ transplantation; Lupus Nephritis; Brain Death; Psoriasis; Amputation, Traumatic; Conjunctivitis, Allergic; Colitis, Ulcerative; Asthma; Surgical Wound Infection; Keratoconjunctivitis; Rejection in heart transplantation; Lung Diseases, Interstitial; Infertility, Female; Nephrotic Syndrome; Renal Insufficiency, Chronic; Coronary Restenosis; Dermatitis, Atopic; Ocular inflammation; Encephalitis; Edema; Peripheral Nerve Injuries; Vitiligo; Crohn Disease; Dermatomyositis; Keratoconjunctivitis Sicca; Rejection of renal transplantation; Polymyositis; Bone marrow transplant rejection; Liver Failure; Genital Diseases, Male; Reperfusion Injury; Medication Adherence; Rejection of lung transplantation; Rejection of liver transplantation; Glomerulonephritis, IGA; Myasthenia Gravis; Primary Graft Dysfunction; Renal Insufficiency; Keratoplasty rejection; Cystitis; Kidney Diseases; Lupus Erythematosus, Cutaneous; Arthritis, Rheumatoid; Graft vs Host Disease; Conjunctivitis; Dry Eye Sy | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Rimiducid | AP-1903 | Phase 1 Clinical | Ariad Pharmaceuticals Inc | Hematologic Neoplasms; Multiple Myeloma; Sarcoma; Neuroblastoma; Osteosarcoma; Melanoma | Details |
This web search service is supported by Google Inc.
A-Z
